Senate Report Brings Scrutiny to Avandia and FDA
Posted on behalf of Phillips Law Group on Feb 22, 2010 in Defective Drug
Senate Report Details Background Issues Regarding Avandia Side Effects
In response to the growing level of concern and number of reports regarding Avandia side effects, the Senate made the decision to formulate and issue a report that analyzed the issue and history of this problematic diabetes medication. Those charged with completing the report reviewed more than 25,000 documents detailing the problems associated with Avandia, and among many conclusions, the following appear to be the most noteworthy:
- Avandia could potentially be responsible for as many as 83,000 heart attacks by those who used the medication.
- GlaxoSmithKline took steps to discredit reports of Avandia side effects and even intimidated doctors who saw the use of Avandia as potentially problematic.
- The FDA overlooked data that should have prompted immediate and strong action.
Every one of these conclusions is a serious indictment of GlaxoSmithKline and the FDA, but unfortunately this report is not legally binding in any manner that could directly lead to action.
Avandia Side Effects Lawyers Now Have More Evidence
Despite the lack of a legally binding characteristic with this Senate report, its conclusions are of the type that many people will notice. Given that Avandia remains on the market, this report is yet further proof and potentially evidence for those who have suffered from Avandia side effects and take the courageous step of enforcing their legal rights. If you or someone you love has suffered harm as a result of using Avandia, you need to contact the Avandia side effects lawyers at Phillips Law Group today to schedule a free initial consultation.